DECIBEL THERAPEUTICS INC (DBTX)
US24343R1068 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 39.80M | 34.61M | 36.45M | 27.74M | 18.60M | |||
| Marketable Securities | 38.50M | 69.95M | 112.29M | 26.57M | 13.71M | |||
| Receivables | N/A | 0.00 | 11.40M | 1.24M | N/A | |||
| Other Current Assets | 2.15M | 3.47M | 4.04M | 2.28M | 1.26M | |||
| Total Current Assets | 80.45M | 108.03M | 164.19M | 57.83M | 33.57M | |||
| Non-Current Assets | ||||||||
| PPE Net | 13.00M | 14.42M | 5.61M | 6.34M | 7.83M | |||
| Investments And Advances | N/A | 0.00 | 13.55M | N/A | N/A | |||
| Other Non-Current Assets | 934.00K | 924.00K | 1.13M | 3.12M | 1.44M | |||
| Total Non-Current Assets | 13.94M | 15.34M | 20.29M | 9.46M | 9.27M | |||
| TOTAL ASSETS | 94.39M | 123.37M | 184.48M | 67.29M | 42.84M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 51.00K | 19.00K | N/A | N/A | N/A | |||
| Accrued Expenses | 13.90M | 11.98M | 7.71M | 5.67M | 4.25M | |||
| Accounts Payable | 617.00K | 1.06M | 4.01M | 2.13M | 1.01M | |||
| Other Current Liabilities | 12.01M | 9.38M | 8.81M | 11.58M | 4.19M | |||
| Total Current Liabilities | 26.58M | 22.44M | 20.54M | 19.37M | 9.45M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 46.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 14.45M | 19.14M | 22.25M | 9.60M | 17.54M | |||
| Total Non-Current Liabilities | 14.50M | 19.14M | 22.25M | 9.61M | 17.54M | |||
| TOTAL LIABILITIES | 41.08M | 41.58M | 42.79M | 28.98M | 26.99M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -308.97M | -277.52M | -214.51M | -162.69M | -123.35M | |||
| Additional Paid In Capital | 362.29M | 359.51M | 356.31M | 107.91M | 1.54M | |||
| Common Shares | 25.00K | 25.00K | 25.00K | 93.09M | 137.64M | |||
| Shares Outstanding | 25.13M | 24.96M | 24.95M | 24.22M | 24.22M | |||
| Tangible Book Value per Share | 2.12 | 3.28 | 5.68 | -2.26 | -5.03 | |||
| Total Shareholders' Equity | 53.31M | 81.79M | 141.69M | 38.31M | 15.85M | |||
| TOTAL LIABILITIES AND EQUITY | 94.39M | 123.37M | 184.48M | 67.29M | 42.84M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 3.03 | 4.81 | 7.99 | 2.99 | 3.55 | |||
| Return On Assets (ROA) | -67.16% | -51.07% | -29.34% | 10.52% | -125.35% | |||
| Return On Equity (ROE) | -118.91% | -77.03% | -38.20% | 18.48% | -338.80% | |||
All data in USD